RxDoctor Payments Data

Alan Gonzalez Blosser, PA

Medical · Southbridge, MANPI 1245654326

Payments from drug & device makers

$636in general payments, 2019–2025

Across 31 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$166
  • Boehringer Ingelheim$137
  • Novo Nordisk$90
  • Lilly USA, LLC$74
  • Johnson & Johnson$57
  • Biohaven Pharmaceutical Holding Company Ltd.$45
  • plus $67 from 3 others

What the payments were for

  • Food & beverage$636100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$636 in reported general payments places this provider in the 70th percentile of 421 medical providers in Massachusetts.

See all medical providers in Massachusetts

Medicare billing

Part B allowed, 2024
$61,055
Medicare patients
335
Services billed
817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin92$106,625
TrulicityDulaglutide61$87,870
OzempicSemaglutide56$71,031
EliquisApixaban57$63,946
JanuviaSitagliptin Phosphate39$55,550
FarxigaDapagliflozin Propanediol26$30,456
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$27,890
Breztri AerosphereBudesonide/Glycopyr/Formoterol41$25,011
MyrbetriqMirabegron24$21,934
Fluticasone Propionate HfaFluticasone Propionate50$14,644
Breo ElliptaFluticasone/Vilanterol29$12,611
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$10,949
Atorvastatin Calcium654$9,007
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate34$6,812
Omeprazole331$4,992

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$137$106,62592 claims
Lilly USA, LLCTrulicity$74$87,87061 claims
Novo NordiskOzempic$90$71,03156 claims
AstraZenecaFarxiga, Breztri Aerosphere$166$55,46767 claims
AbbVieSynthroid$24$1,07212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 421 medical providers in Massachusetts.

Other medical in Southbridge

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →